Bleeding complications in patients with acute coronary syndrome undergoing early invasive management can be reduced with radial access, smaller sheath sizes, and timely sheath removal
Catheterization and Cardiovascular Interventions2006Vol. 69(1), pp. 73–83
Citations Over TimeTop 10% of 2006 papers
Warren J. Cantor, Kenneth W. Mahaffey, Zhen Huang, Pranab Das, Dietrich C. Gulba, Stanislav Glezer, Richard L. Gallo, John Ducas, Marc Cohen, Elliott M. Antman, Anatoly Langer, Neal S. Kleiman, Harvey D. White, Robert J. Chisholm, Robert A. Harrington, James J. Ferguson, Robert M. Califf, Shaun G. Goodman
Abstract
Smaller sheaths, radial access, and timely sheath removal may mitigate the bleeding risk associated with potent antithrombotic/platelet therapy and early catheterization.
Related Papers
- → Sensitivity of a Modified ACT Test to Levels of Bivalirudin Used During Cardiac Surgery(2005)36 cited
- → Comparison of two pediatric cases requiring the use of bivalirudin during cardiopulmonary bypass(2018)7 cited
- Optimizing management of hirudin anticoagulation.(2005)
- → A new rapid ecarin clotting time assay but not activated clotting time strongly correlates with bivalirudin concentration: a percutaneous coronary intervention study(2002)1 cited
- → TCT-752 Ecarin Clotting Time (ECT) more accurately reflects bivalirudin concentration than Activated Clotting Time (ACT) in patients undergoing Percutaneous Coronary Intervention using bivalirudin anticoagulation(2012)